WEREWOLF THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WEREWOLF THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- WEREWOLF THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- WEREWOLF THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- WEREWOLF THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares S-4 · filed 2026-09-22 | 0.00 shares derived: sum of 4 quarters · filed 2026-09-22 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-12-31 | 0.00 shares derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | 0.00 shares S-4 · filed 2026-09-22 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 0.00 shares S-4 · filed 2026-09-22 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-03 | |
| 2022-09-30 | 32.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2022-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 46.00K shares 10-Q · filed 2022-05-10 | |
| 2021-09-30 | 7.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | 29.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | 13.00K shares 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |